Company Summary - Immunodiagnostic Systems Holdings PLC (LSE:IDH)
509.50p
0.50p
(-0.10%)
FTSE AIM UK 50 Health Care Equipment & ServicesMarket cap: £134.921m
Review a company's summary page in more detail and see the key fundamentals at a glance. Sign-up to Premium now to make your investment decisions.
Sign-up to Premium's Free 7 Day trial See an improved company summary
Summary
Manufacturing and distributing medical diagnostic products
| Financials - Annual Report (31/03/2009) | ||
|---|---|---|
| Turnover | £m | 24.94 |
| Pre-tax Profit | £m | 4.78 |
| EPS | p | 17.82 |
| DPS | p | 1.5 |
| Dividend Yield | % | .294 |
| Director | Board Role |
|---|---|
| David Evans | Chairman |
| Dr. Roger Duggan | Chief Executive |
| Paul Hailes | Finance Director & Company Sec |
| Tony Wilks | Sales/Mkt Director |
Products Brands & Subsidiaries
Products & Brands
There are no products for this company.
Subsidiaries
IDS GmbH; Suomen Bioanalytiikka Oy (SBA Sciences Ltd); Immunodiagnostic Systems Ltd; Immunodiagnostic Systems France SA...
Broker Sentiment (4 brokers)
Strong SellStrong Buy
| Heading | Date |
|---|---|
| Allotment of shares | 07/10/2009 |
| Trading Update | 05/10/2009 |
| Director/PDMR Shareholding | 15/09/2009 |